Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
0 hedge funds and large institutions have $0 invested in Allergan Inc in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 9 closing their positions.
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $3.66M → $0 (-$3.66M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Callahan Advisors
Houston,
Texas
|
-$2.22M |
| 2 |
MMPW
Mitchell McLeod Pugh & Williams
Mobile,
Alabama
|
-$705K |
| 3 |
CA
Cullinan Associates
Louisville,
Kentucky
|
-$354K |
| 4 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
-$248K |
| 5 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
-$79K |
AGN Hedge Fund Activity: Q2 2020 in Review
0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2020, worth a combined $0 — down 100% from $3.66M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AGN and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Callahan Advisors, exiting entirely with an estimated $2.22M sold.
- 0 institutional investors held Allergan Inc (AGN) as of Q2 2020, down from 9 in Q1 2020.
- Funds reported $0 of Allergan Inc stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new Allergan Inc positions in Q2 2020 and 9 closed out, a net change of -9 holders.
- The largest Allergan Inc seller in Q2 2020 was Callahan Advisors, an estimated $2.22M sold.
Based on aggregated 13F filings for Q2 2020.